Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Sep 11, 2023
Episode
174
Soundcloud
Share
Monday at WCLC 2023 features the Presidential Symposium. In this special WCLC 2023 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu talk with Dr. Eric Lim about MARS 2: A Multicentre Randomized Trial Comparing (Extended) Pleurectomy Decortication versus No Radical Surgery for Mesothelioma. Dr. Paula Ugalde, discussant for MARS 2, provides her unique overview and perspective on research presented today. The hosts also talk with Dr. P.C. Yang about the new results presented in the TALENT study of lung cancer screening in Taiwan. Additionally, Dr. Pasi Janne summarizes his presidential abstract: Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2) and is joined in a discussion withEmi Bossio, a patient research advocate and board member of Lung Cancer Canada.
Guest
Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Patient Research Advocate
Board Member of Lung Cancer Canada
Pasi Janne
MD, PhD
Professor of Medicine
Dana Farber Cancer Institute, Harvard Medical School
Eric Lim
MD, MB, ChB, MSc, FRCS
Royal Brompton Hospital
Paula Ugalde
MD
Associate Surgeon, Division of Thoracic Surgery
Brigham and Women's Hospital
Pan-Chyr Yang
MD, PhD
National Taiwan University College of Medicine
National Taiwan University Hospital
Institute of Biomedical Sciences
